Cara Therapeutics | CARA - Des Atouts

Prix De L'Action
3.64
Variation Quotidienne
0.12 3.27%
Mensuellement
-2.81%
Annuel
-78.44%
Q1 Prévisions
3.41




Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Assertio Holdings USD 319.77M 46M 2025-09
Cara Therapeutics USD 43.75M 4.8M 2025-06
Cassava Sciences USD 118.35M 11.38M 2025-12
Chugai Pharma JPY 2.47T 285.01B 2025-12
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
J&J USD 199.21B 6.39B 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
RedHill Biopharma USD 18.38M 332K 2025-06
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12